394 related articles for article (PubMed ID: 30354268)
41. The role of multiparametric MRI in differentiating uterine leiomyosarcoma from benign degenerative leiomyoma and leiomyoma variants: a retrospective analysis.
Mahmood NS; Al Rashid AA; Ladumor SB; Mohamed MA; Kambal AS; Saloum N; Mohamed SEMK; Al Hyassat S; Singh R
Clin Radiol; 2023 Jan; 78(1):47-54. PubMed ID: 36220736
[TBL] [Abstract][Full Text] [Related]
42. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
43. Diagnostic Accuracy of Ultrasound, Contrast-enhanced CT, and Conventional MRI for Differentiating Leiomyoma From Leiomyosarcoma.
Gaetke-Udager K; McLean K; Sciallis AP; Alves T; Maturen KE; Mervak BM; Moore AG; Wasnik AP; Erba J; Davenport MS
Acad Radiol; 2016 Oct; 23(10):1290-7. PubMed ID: 27396800
[TBL] [Abstract][Full Text] [Related]
44. Variant type of leiomyomas: 13 years of experience in a single institution.
Bacanakgil BH; Ilhan G; Kaban I
Ginekol Pol; 2022; 93(6):444-449. PubMed ID: 34155617
[TBL] [Abstract][Full Text] [Related]
45. Power Morcellation of Unsuspected High-grade Leiomyosarcoma Within an Inflated Containment Bag: 2-year Follow-up.
Boruta DM; Shibley T
J Minim Invasive Gynecol; 2016; 23(6):1009-11. PubMed ID: 27393286
[TBL] [Abstract][Full Text] [Related]
46. Risk of Occult Uterine Sarcoma in Presumed Uterine Fibroids.
Cui RR; Wright JD
Clin Obstet Gynecol; 2016 Mar; 59(1):103-18. PubMed ID: 26645385
[TBL] [Abstract][Full Text] [Related]
47. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
48. What is the Future of Open Intraperitoneal Power-Morcellation of Fibroids?
Parker WH; Pritts EA; Olive DL
Clin Obstet Gynecol; 2016 Mar; 59(1):73-84. PubMed ID: 26670834
[TBL] [Abstract][Full Text] [Related]
49. Imaging techniques for evaluation of uterine myomas.
Testa AC; Di Legge A; Bonatti M; Manfredi R; Scambia G
Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():37-53. PubMed ID: 26803557
[TBL] [Abstract][Full Text] [Related]
50. Multiparametric MR evaluation of uterine leiomyosarcoma and STUMP versus leiomyoma in symptomatic women planned for high frequency focussed ultrasound: accuracy of imaging parameters and interobserver agreement for identification of malignancy.
Aminzadeh P; Alibrahim E; Dobrotwir A; Paul E; Goergen S
Br J Radiol; 2021 Mar; 94(1119):20200483. PubMed ID: 33507806
[TBL] [Abstract][Full Text] [Related]
51. Positron emission tomography and uterine leiomyomas.
Lee WL; Yuan CC; Wang PH
Gynecol Oncol; 2007 Dec; 107(3):593-4; author reply 594-5. PubMed ID: 17826823
[No Abstract] [Full Text] [Related]
52. Mass lesions of the myometrium: interpretation and management of unexpected pathology.
Porter AE; Kho KA; Gwin K
Curr Opin Obstet Gynecol; 2019 Oct; 31(5):349-355. PubMed ID: 31425175
[TBL] [Abstract][Full Text] [Related]
53. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroids: an updated decision analysis following the 2014 Food and Drug Administration safety communications.
Siedhoff MT; Doll KM; Clarke-Pearson DL; Rutstein SE
Am J Obstet Gynecol; 2017 Mar; 216(3):259.e1-259.e6. PubMed ID: 27890646
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.
Abdel Wahab C; Jannot AS; Bonaffini PA; Bourillon C; Cornou C; Lefrère-Belda MA; Bats AS; Thomassin-Naggara I; Bellucci A; Reinhold C; Fournier LS
Radiology; 2020 Nov; 297(2):361-371. PubMed ID: 32930650
[TBL] [Abstract][Full Text] [Related]
55. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound.
Stovall DW
Menopause; 2011 Apr; 18(4):437-44. PubMed ID: 21701430
[TBL] [Abstract][Full Text] [Related]
56. Molecular Bio-Imaging Probe for Non-Invasive Differentiation Between Human Leiomyoma Versus Leiomyosarcoma.
Shalaby S; Khater M; Laknaur A; Arbab A; Al-Hendy A
Reprod Sci; 2020 Feb; 27(2):644-654. PubMed ID: 31925772
[TBL] [Abstract][Full Text] [Related]
57. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Parker W; Pritts E; Olive D
J Minim Invasive Gynecol; 2015; 22(4):696-7. PubMed ID: 25623370
[No Abstract] [Full Text] [Related]
58. Uterine Fibroid in a 16-Year-Old Adolescent Managed with a Fertility-Sparing Approach: A Case Report and Review of the Literature.
Murphy CA; Zarudskaya O; Kakish C; Zoorob D; Seo-Patel S
J Pediatr Adolesc Gynecol; 2021 Jun; 34(3):427-431. PubMed ID: 33359317
[TBL] [Abstract][Full Text] [Related]
59. MRI, clinical, and radiomic models for differentiation of uterine leiomyosarcoma and leiomyoma.
Roller LA; Wan Q; Liu X; Qin L; Chapel D; Burk KS; Guo Y; Shinagare AB
Abdom Radiol (NY); 2024 May; 49(5):1522-1533. PubMed ID: 38467853
[TBL] [Abstract][Full Text] [Related]
60. The selected biomarker analysis in 5 types of uterine smooth muscle tumors.
Zhang Q; Kanis MJ; Ubago J; Liu D; Scholtens DM; Strohl AE; Lurain JR; Shahabi S; Kong B; Wei JJ
Hum Pathol; 2018 Jun; 76():17-27. PubMed ID: 29258902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
